Thomas J. Schuetz's Net Worth
$12.8 Million
Who is Thomas J. Schuetz?
Thomas J. Schuetz has an estimated net worth of $12.8 Million. This is based on reported shares across multiple companies, which include Relypsa Inc, Compass Therapeutics, Inc., and Audentes Therapeutics, Inc..
SEC CIK
Thomas J. Schuetz's CIK is 0001591464
Past Insider Trading and Trends
2022 was Thomas J. Schuetz's most active year for acquiring shares with 18 total transactions. Thomas J. Schuetz's most active month to acquire stocks was the month of May. 2016 was Thomas J. Schuetz's most active year for disposing of shares, totalling 12 transactions. Thomas J. Schuetz's most active month to dispose stocks was the month of August. 2024 saw Thomas J. Schuetz paying a total of $1,230,375.00 for 1,275,000 shares, this is the most they've acquired in one year. In 2020 Thomas J. Schuetz cashed out on 157,586 shares for a total of $5,381,700.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Relypsa Inc No price found
InvestorThomas J. Schuetz used to own units in Common Stock but no longer holds any shares there.acquired a total of 37,212 shares in Relypsa Inc at a cost of $401,832.00, Thomas also disposed a total of 37,212 shares of Relypsa Inc equalling to $1,193,355.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -36.21K |
$32.00 | -$1,158,784.00 |
0
|
Sep 1
| |||
Form 4
| +6.63% | 2.25K |
—
|
—
| 36.21K |
Jun 21
| |||
Form 4
| +757.19% | 30K |
$13.39 | $401,832.00 | 33.96K |
Mar 15
| |||
Form 4
| -20.15% | -1.00K |
$34.57 | -$34,571.00 | 3.96K |
Scheduled
|
Jun 11
| ||
Form 4
| +82.96% | 2.25K |
—
|
—
| 4.96K |
Jun 4
| |||
Form 4
|
∞
| 2.71K |
—
|
—
| 2.71K |
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Compass Therapeutics, Inc. (CMPX) Snapshot price: $1.43
PRESIDENTThomas J. Schuetz owns 6,570,566 units of Common Stock which is worth $9,395,909.38. From 2020 to 2024 Thomas J. Schuetz acquired a total of 2,231,337 shares in Compass Therapeutics, Inc. at a cost of $2,869,791.45, Thomas also disposed a total of 88,807 shares of Compass Therapeutics, Inc. equalling to $130,971.40.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.68% | -44.78K |
$1.45 | -$64,933.90 | 6.57M |
Feb 8
| |||
Form 4
| +10.66% | 637.5K |
$1.93 | $1,230,375.00 | 6.62M |
Jan 9
| |||
Form 4
| -0.73% | -44.02K |
$1.50 | -$66,037.50 | 5.98M |
Nov 17
| |||
Form 4
| +0.17% | 10K |
$3.37 | $33,700.00 | 6.02M |
Mar 10
| |||
Form 4
| +0.33% | 20K |
$3.98 | $79,600.00 | 6.01M |
Feb 27
| |||
Form 4
| +0.33% | 20K |
$3.86 | $77,200.00 | 5.99M |
Feb 15
| |||
Form 4
| +9.14% | 500K |
—
|
—
| 5.97M |
Feb 8
| |||
Form 4
| +0.37% | 20K |
$4.05 | $81,000.00 | 5.47M |
Jan 31
| |||
Form 4
| +0.37% | 20K |
$4.19 | $83,800.00 | 5.45M |
Jan 24
| |||
Form 4
| +0.18% | 10K |
$2.32 | $23,200.00 | 5.43M |
Sep 28
| |||
Form 4
| +0.28% | 15K |
$2.27 | $34,050.00 | 5.42M |
Sep 26
| |||
Form 4
| +0.28% | 15K |
$3.03 | $45,450.00 | 5.41M |
Sep 7
| |||
Form 4
| +0.28% | 15K |
$2.83 | $42,450.00 | 5.39M |
Sep 1
| |||
Form 4
| +0.28% | 15K |
$3.05 | $45,750.00 | 5.38M |
Aug 17
| |||
Form 4
| +0.28% | 15K |
$2.64 | $39,600.00 | 5.36M |
Aug 10
| |||
Form 4
| +0.28% | 15K |
$2.58 | $38,700.00 | 5.35M |
Aug 1
| |||
Form 4
| +0.38% | 20K |
$2.80 | $56,000.00 | 5.33M |
Jun 21
| |||
Form 4
| +0.38% | 20K |
$2.34 | $46,800.00 | 5.31M |
Jun 16
| |||
Form 4
| +0.57% | 30K |
$2.29 | $68,700.00 | 5.29M |
Jun 13
| |||
Form 4
| +0.57% | 30K |
$2.83 | $84,900.00 | 5.26M |
Jun 6
| |||
Form 4
| +0.38% | 20K |
$3.03 | $60,600.00 | 5.23M |
Jun 1
| |||
Form 4
| +0.39% | 20K |
$3.04 | $60,800.00 | 5.21M |
May 26
| |||
Form 4
| +0.35% | 18.36K |
$2.72 | $49,925.60 | 5.19M |
May 23
| |||
Form 4
| +0.39% | 20.21K |
$2.47 | $49,931.05 | 5.17M |
May 17
| |||
Form 4
| +0.54% | 27.84K |
$1.80 | $50,104.80 | 5.15M |
May 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +13.26% | 600K |
—
|
—
| 5.13M |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 4
| +2.20% | 97.43K |
$5.00 | $487,155.00 | 4.53M |
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Audentes Therapeutics, Inc. No price found
InvestorThomas J. Schuetz used to own units in Common Stock but no longer holds any shares there. In the year 2016 Thomas J. Schuetz filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -89.69K |
$60.00 | -$5,381,700.00 |
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||